nodes	percent_of_prediction	percent_of_DWPC	metapath
Rescinnamine—Voacamine—Vincristine—peripheral nervous system neoplasm	0.764	1	CrCrCtD
Rescinnamine—ACE—forelimb zeugopod—peripheral nervous system neoplasm	0.0135	0.319	CbGeAlD
Rescinnamine—ACE—forelimb—peripheral nervous system neoplasm	0.00679	0.16	CbGeAlD
Rescinnamine—ACE—arm—peripheral nervous system neoplasm	0.00584	0.138	CbGeAlD
Rescinnamine—SLC18A2—ganglion—peripheral nervous system neoplasm	0.00538	0.127	CbGeAlD
Rescinnamine—ACE—nerve—peripheral nervous system neoplasm	0.00372	0.0877	CbGeAlD
Rescinnamine—ACE—ganglion—peripheral nervous system neoplasm	0.00367	0.0866	CbGeAlD
Rescinnamine—SLC18A2—brainstem—peripheral nervous system neoplasm	0.00234	0.0551	CbGeAlD
Rescinnamine—Voacamine—ABCB1—peripheral nervous system neoplasm	0.0018	0.647	CrCbGaD
Rescinnamine—SLC18A2—cerebellum—peripheral nervous system neoplasm	0.00115	0.0272	CbGeAlD
Rescinnamine—Reserpine—ABCB1—peripheral nervous system neoplasm	0.000979	0.353	CrCbGaD
Rescinnamine—Stinging—Doxorubicin—peripheral nervous system neoplasm	0.000429	0.00224	CcSEcCtD
Rescinnamine—Hypoaesthesia—Alitretinoin—peripheral nervous system neoplasm	0.000429	0.00224	CcSEcCtD
Rescinnamine—Pharyngitis—Alitretinoin—peripheral nervous system neoplasm	0.000428	0.00224	CcSEcCtD
Rescinnamine—Hypertension—Tretinoin—peripheral nervous system neoplasm	0.000427	0.00224	CcSEcCtD
Rescinnamine—Hypertension—Isotretinoin—peripheral nervous system neoplasm	0.000427	0.00224	CcSEcCtD
Rescinnamine—Cough—Melphalan—peripheral nervous system neoplasm	0.000426	0.00223	CcSEcCtD
Rescinnamine—Myalgia—Topotecan—peripheral nervous system neoplasm	0.000425	0.00222	CcSEcCtD
Rescinnamine—Myalgia—Tretinoin—peripheral nervous system neoplasm	0.000421	0.0022	CcSEcCtD
Rescinnamine—Myalgia—Isotretinoin—peripheral nervous system neoplasm	0.000421	0.0022	CcSEcCtD
Rescinnamine—Discomfort—Topotecan—peripheral nervous system neoplasm	0.00042	0.0022	CcSEcCtD
Rescinnamine—Discomfort—Isotretinoin—peripheral nervous system neoplasm	0.000416	0.00218	CcSEcCtD
Rescinnamine—Discomfort—Tretinoin—peripheral nervous system neoplasm	0.000416	0.00218	CcSEcCtD
Rescinnamine—Myalgia—Melphalan—peripheral nervous system neoplasm	0.000416	0.00218	CcSEcCtD
Rescinnamine—Skin discolouration—Epirubicin—peripheral nervous system neoplasm	0.000416	0.00218	CcSEcCtD
Rescinnamine—Hypoaesthesia—Vincristine—peripheral nervous system neoplasm	0.000413	0.00216	CcSEcCtD
Rescinnamine—Cough increased—Epirubicin—peripheral nervous system neoplasm	0.00041	0.00215	CcSEcCtD
Rescinnamine—Lacrimation increased—Epirubicin—peripheral nervous system neoplasm	0.000407	0.00213	CcSEcCtD
Rescinnamine—Erythema—Dactinomycin—peripheral nervous system neoplasm	0.000404	0.00212	CcSEcCtD
Rescinnamine—Infection—Topotecan—peripheral nervous system neoplasm	0.000404	0.00212	CcSEcCtD
Rescinnamine—Oedema—Tretinoin—peripheral nervous system neoplasm	0.000404	0.00211	CcSEcCtD
Rescinnamine—Oedema—Isotretinoin—peripheral nervous system neoplasm	0.000404	0.00211	CcSEcCtD
Rescinnamine—Acute coronary syndrome—Cisplatin—peripheral nervous system neoplasm	0.000403	0.00211	CcSEcCtD
Rescinnamine—Infection—Tretinoin—peripheral nervous system neoplasm	0.000401	0.0021	CcSEcCtD
Rescinnamine—Infection—Isotretinoin—peripheral nervous system neoplasm	0.000401	0.0021	CcSEcCtD
Rescinnamine—Myocardial infarction—Cisplatin—peripheral nervous system neoplasm	0.000401	0.0021	CcSEcCtD
Rescinnamine—Oedema—Melphalan—peripheral nervous system neoplasm	0.000399	0.00209	CcSEcCtD
Rescinnamine—Conjunctivitis—Cisplatin—peripheral nervous system neoplasm	0.000397	0.00208	CcSEcCtD
Rescinnamine—Infection—Melphalan—peripheral nervous system neoplasm	0.000396	0.00207	CcSEcCtD
Rescinnamine—Skin discolouration—Doxorubicin—peripheral nervous system neoplasm	0.000385	0.00201	CcSEcCtD
Rescinnamine—Cough increased—Doxorubicin—peripheral nervous system neoplasm	0.000379	0.00199	CcSEcCtD
Rescinnamine—Lacrimation increased—Doxorubicin—peripheral nervous system neoplasm	0.000377	0.00197	CcSEcCtD
Rescinnamine—Vaginal inflammation—Epirubicin—peripheral nervous system neoplasm	0.000375	0.00196	CcSEcCtD
Rescinnamine—Erythema—Alitretinoin—peripheral nervous system neoplasm	0.000375	0.00196	CcSEcCtD
Rescinnamine—Dermatitis contact—Epirubicin—peripheral nervous system neoplasm	0.000371	0.00194	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Topotecan—peripheral nervous system neoplasm	0.000371	0.00194	CcSEcCtD
Rescinnamine—Acute coronary syndrome—Etoposide—peripheral nervous system neoplasm	0.000369	0.00193	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Tretinoin—peripheral nervous system neoplasm	0.000368	0.00193	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Isotretinoin—peripheral nervous system neoplasm	0.000368	0.00193	CcSEcCtD
Rescinnamine—Myocardial infarction—Etoposide—peripheral nervous system neoplasm	0.000367	0.00192	CcSEcCtD
Rescinnamine—Paraesthesia—Topotecan—peripheral nervous system neoplasm	0.000366	0.00191	CcSEcCtD
Rescinnamine—Insomnia—Tretinoin—peripheral nervous system neoplasm	0.000365	0.00191	CcSEcCtD
Rescinnamine—Insomnia—Isotretinoin—peripheral nervous system neoplasm	0.000365	0.00191	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Melphalan—peripheral nervous system neoplasm	0.000363	0.0019	CcSEcCtD
Rescinnamine—Back pain—Alitretinoin—peripheral nervous system neoplasm	0.000363	0.0019	CcSEcCtD
Rescinnamine—Paraesthesia—Tretinoin—peripheral nervous system neoplasm	0.000363	0.0019	CcSEcCtD
Rescinnamine—Paraesthesia—Isotretinoin—peripheral nervous system neoplasm	0.000363	0.0019	CcSEcCtD
Rescinnamine—Paraesthesia—Melphalan—peripheral nervous system neoplasm	0.000358	0.00187	CcSEcCtD
Rescinnamine—Vaginal infection—Epirubicin—peripheral nervous system neoplasm	0.000354	0.00185	CcSEcCtD
Rescinnamine—Back pain—Vincristine—peripheral nervous system neoplasm	0.00035	0.00183	CcSEcCtD
Rescinnamine—Pain—Topotecan—peripheral nervous system neoplasm	0.000348	0.00182	CcSEcCtD
Rescinnamine—Constipation—Topotecan—peripheral nervous system neoplasm	0.000348	0.00182	CcSEcCtD
Rescinnamine—Vaginal inflammation—Doxorubicin—peripheral nervous system neoplasm	0.000347	0.00182	CcSEcCtD
Rescinnamine—Pain—Tretinoin—peripheral nervous system neoplasm	0.000345	0.00181	CcSEcCtD
Rescinnamine—Constipation—Tretinoin—peripheral nervous system neoplasm	0.000345	0.00181	CcSEcCtD
Rescinnamine—Constipation—Isotretinoin—peripheral nervous system neoplasm	0.000345	0.00181	CcSEcCtD
Rescinnamine—Pain—Isotretinoin—peripheral nervous system neoplasm	0.000345	0.00181	CcSEcCtD
Rescinnamine—Myalgia—Dactinomycin—peripheral nervous system neoplasm	0.000344	0.0018	CcSEcCtD
Rescinnamine—Dermatitis contact—Doxorubicin—peripheral nervous system neoplasm	0.000343	0.0018	CcSEcCtD
Rescinnamine—Pain—Melphalan—peripheral nervous system neoplasm	0.000341	0.00178	CcSEcCtD
Rescinnamine—Discomfort—Dactinomycin—peripheral nervous system neoplasm	0.00034	0.00178	CcSEcCtD
Rescinnamine—Hypoaesthesia—Etoposide—peripheral nervous system neoplasm	0.000335	0.00175	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Topotecan—peripheral nervous system neoplasm	0.000333	0.00174	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Isotretinoin—peripheral nervous system neoplasm	0.00033	0.00173	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Tretinoin—peripheral nervous system neoplasm	0.00033	0.00173	CcSEcCtD
Rescinnamine—Oedema—Dactinomycin—peripheral nervous system neoplasm	0.00033	0.00173	CcSEcCtD
Rescinnamine—Hypertonia—Epirubicin—peripheral nervous system neoplasm	0.000329	0.00172	CcSEcCtD
Rescinnamine—Infection—Dactinomycin—peripheral nervous system neoplasm	0.000328	0.00172	CcSEcCtD
Rescinnamine—Vaginal infection—Doxorubicin—peripheral nervous system neoplasm	0.000328	0.00172	CcSEcCtD
Rescinnamine—Cough—Alitretinoin—peripheral nervous system neoplasm	0.000327	0.00171	CcSEcCtD
Rescinnamine—Hypertension—Alitretinoin—peripheral nervous system neoplasm	0.000324	0.00169	CcSEcCtD
Rescinnamine—Urticaria—Topotecan—peripheral nervous system neoplasm	0.000323	0.00169	CcSEcCtD
Rescinnamine—Abdominal pain—Topotecan—peripheral nervous system neoplasm	0.000322	0.00168	CcSEcCtD
Rescinnamine—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.000321	0.00168	CcSEcCtD
Rescinnamine—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.000321	0.00168	CcSEcCtD
Rescinnamine—Erythema—Cisplatin—peripheral nervous system neoplasm	0.00032	0.00167	CcSEcCtD
Rescinnamine—Myalgia—Alitretinoin—peripheral nervous system neoplasm	0.000319	0.00167	CcSEcCtD
Rescinnamine—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.000319	0.00167	CcSEcCtD
Rescinnamine—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.000319	0.00167	CcSEcCtD
Rescinnamine—Urticaria—Melphalan—peripheral nervous system neoplasm	0.000317	0.00166	CcSEcCtD
Rescinnamine—Discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000315	0.00165	CcSEcCtD
Rescinnamine—Hypertension—Vincristine—peripheral nervous system neoplasm	0.000312	0.00163	CcSEcCtD
Rescinnamine—Myalgia—Vincristine—peripheral nervous system neoplasm	0.000308	0.00161	CcSEcCtD
Rescinnamine—Oedema—Alitretinoin—peripheral nervous system neoplasm	0.000306	0.0016	CcSEcCtD
Rescinnamine—Hypertonia—Doxorubicin—peripheral nervous system neoplasm	0.000304	0.00159	CcSEcCtD
Rescinnamine—Infection—Alitretinoin—peripheral nervous system neoplasm	0.000304	0.00159	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Dactinomycin—peripheral nervous system neoplasm	0.000301	0.00157	CcSEcCtD
Rescinnamine—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.0003	0.00157	CcSEcCtD
Rescinnamine—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.000298	0.00156	CcSEcCtD
Rescinnamine—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.000298	0.00156	CcSEcCtD
Rescinnamine—Oedema—Vincristine—peripheral nervous system neoplasm	0.000295	0.00154	CcSEcCtD
Rescinnamine—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.000294	0.00154	CcSEcCtD
Rescinnamine—Infection—Vincristine—peripheral nervous system neoplasm	0.000293	0.00153	CcSEcCtD
Rescinnamine—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000288	0.00151	CcSEcCtD
Rescinnamine—Dysgeusia—Etoposide—peripheral nervous system neoplasm	0.000287	0.0015	CcSEcCtD
Rescinnamine—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000286	0.0015	CcSEcCtD
Rescinnamine—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000286	0.0015	CcSEcCtD
Rescinnamine—Dermatitis bullous—Epirubicin—peripheral nervous system neoplasm	0.000285	0.00149	CcSEcCtD
Rescinnamine—Back pain—Etoposide—peripheral nervous system neoplasm	0.000283	0.00148	CcSEcCtD
Rescinnamine—Pain—Dactinomycin—peripheral nervous system neoplasm	0.000282	0.00148	CcSEcCtD
Rescinnamine—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000282	0.00148	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000279	0.00146	CcSEcCtD
Rescinnamine—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.000277	0.00145	CcSEcCtD
Rescinnamine—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.000275	0.00144	CcSEcCtD
Rescinnamine—Myalgia—Cisplatin—peripheral nervous system neoplasm	0.000272	0.00142	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.00027	0.00141	CcSEcCtD
Rescinnamine—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000269	0.00141	CcSEcCtD
Rescinnamine—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.000269	0.00141	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000269	0.00141	CcSEcCtD
Rescinnamine—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000267	0.0014	CcSEcCtD
Rescinnamine—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000267	0.0014	CcSEcCtD
Rescinnamine—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000267	0.0014	CcSEcCtD
Rescinnamine—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000265	0.00139	CcSEcCtD
Rescinnamine—Dermatitis bullous—Doxorubicin—peripheral nervous system neoplasm	0.000264	0.00138	CcSEcCtD
Rescinnamine—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000262	0.00137	CcSEcCtD
Rescinnamine—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000262	0.00137	CcSEcCtD
Rescinnamine—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000261	0.00137	CcSEcCtD
Rescinnamine—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000261	0.00136	CcSEcCtD
Rescinnamine—Infection—Cisplatin—peripheral nervous system neoplasm	0.000259	0.00136	CcSEcCtD
Rescinnamine—Rash—Topotecan—peripheral nervous system neoplasm	0.000257	0.00134	CcSEcCtD
Rescinnamine—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000256	0.00134	CcSEcCtD
Rescinnamine—Cough—Etoposide—peripheral nervous system neoplasm	0.000255	0.00134	CcSEcCtD
Rescinnamine—Headache—Topotecan—peripheral nervous system neoplasm	0.000255	0.00133	CcSEcCtD
Rescinnamine—Rash—Tretinoin—peripheral nervous system neoplasm	0.000255	0.00133	CcSEcCtD
Rescinnamine—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000255	0.00133	CcSEcCtD
Rescinnamine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000254	0.00133	CcSEcCtD
Rescinnamine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000254	0.00133	CcSEcCtD
Rescinnamine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000253	0.00132	CcSEcCtD
Rescinnamine—Headache—Tretinoin—peripheral nervous system neoplasm	0.000253	0.00132	CcSEcCtD
Rescinnamine—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000253	0.00132	CcSEcCtD
Rescinnamine—Pain—Vincristine—peripheral nervous system neoplasm	0.000252	0.00132	CcSEcCtD
Rescinnamine—Constipation—Vincristine—peripheral nervous system neoplasm	0.000252	0.00132	CcSEcCtD
Rescinnamine—Rash—Melphalan—peripheral nervous system neoplasm	0.000251	0.00132	CcSEcCtD
Rescinnamine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000251	0.00131	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.00025	0.00131	CcSEcCtD
Rescinnamine—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000246	0.00129	CcSEcCtD
Rescinnamine—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000243	0.00127	CcSEcCtD
Rescinnamine—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000243	0.00127	CcSEcCtD
Rescinnamine—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000242	0.00127	CcSEcCtD
Rescinnamine—Nausea—Topotecan—peripheral nervous system neoplasm	0.000242	0.00127	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000241	0.00126	CcSEcCtD
Rescinnamine—Gastritis—Epirubicin—peripheral nervous system neoplasm	0.000241	0.00126	CcSEcCtD
Rescinnamine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00024	0.00126	CcSEcCtD
Rescinnamine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00024	0.00126	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000238	0.00124	CcSEcCtD
Rescinnamine—Infection—Etoposide—peripheral nervous system neoplasm	0.000237	0.00124	CcSEcCtD
Rescinnamine—Nausea—Melphalan—peripheral nervous system neoplasm	0.000237	0.00124	CcSEcCtD
Rescinnamine—Influenza—Epirubicin—peripheral nervous system neoplasm	0.000236	0.00123	CcSEcCtD
Rescinnamine—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000234	0.00123	CcSEcCtD
Rescinnamine—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000233	0.00122	CcSEcCtD
Rescinnamine—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.000229	0.0012	CcSEcCtD
Rescinnamine—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.000226	0.00119	CcSEcCtD
Rescinnamine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000226	0.00118	CcSEcCtD
Rescinnamine—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.000223	0.00117	CcSEcCtD
Rescinnamine—Pain—Cisplatin—peripheral nervous system neoplasm	0.000223	0.00117	CcSEcCtD
Rescinnamine—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.000218	0.00114	CcSEcCtD
Rescinnamine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000217	0.00114	CcSEcCtD
Rescinnamine—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000217	0.00113	CcSEcCtD
Rescinnamine—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.000215	0.00113	CcSEcCtD
Rescinnamine—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000215	0.00112	CcSEcCtD
Rescinnamine—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000212	0.00111	CcSEcCtD
Rescinnamine—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.00021	0.0011	CcSEcCtD
Rescinnamine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000208	0.00109	CcSEcCtD
Rescinnamine—Pain—Etoposide—peripheral nervous system neoplasm	0.000204	0.00107	CcSEcCtD
Rescinnamine—Constipation—Etoposide—peripheral nervous system neoplasm	0.000204	0.00107	CcSEcCtD
Rescinnamine—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000204	0.00107	CcSEcCtD
Rescinnamine—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000204	0.00107	CcSEcCtD
Rescinnamine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000202	0.00106	CcSEcCtD
Rescinnamine—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000199	0.00104	CcSEcCtD
Rescinnamine—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000197	0.00103	CcSEcCtD
Rescinnamine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000196	0.00103	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000195	0.00102	CcSEcCtD
Rescinnamine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000195	0.00102	CcSEcCtD
Rescinnamine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000193	0.00101	CcSEcCtD
Rescinnamine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000193	0.00101	CcSEcCtD
Rescinnamine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000192	0.00101	CcSEcCtD
Rescinnamine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000192	0.001	CcSEcCtD
Rescinnamine—Urticaria—Etoposide—peripheral nervous system neoplasm	0.00019	0.000993	CcSEcCtD
Rescinnamine—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000189	0.000989	CcSEcCtD
Rescinnamine—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000189	0.000988	CcSEcCtD
Rescinnamine—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000189	0.000988	CcSEcCtD
Rescinnamine—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000189	0.000988	CcSEcCtD
Rescinnamine—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000188	0.000982	CcSEcCtD
Rescinnamine—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000187	0.000979	CcSEcCtD
Rescinnamine—Rash—Vincristine—peripheral nervous system neoplasm	0.000186	0.000973	CcSEcCtD
Rescinnamine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000186	0.000972	CcSEcCtD
Rescinnamine—Headache—Vincristine—peripheral nervous system neoplasm	0.000185	0.000967	CcSEcCtD
Rescinnamine—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000182	0.000954	CcSEcCtD
Rescinnamine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000182	0.000951	CcSEcCtD
Rescinnamine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000176	0.000921	CcSEcCtD
Rescinnamine—Nausea—Vincristine—peripheral nervous system neoplasm	0.000175	0.000917	CcSEcCtD
Rescinnamine—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000175	0.000915	CcSEcCtD
Rescinnamine—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000174	0.000908	CcSEcCtD
Rescinnamine—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000173	0.000906	CcSEcCtD
Rescinnamine—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000169	0.000885	CcSEcCtD
Rescinnamine—Rash—Cisplatin—peripheral nervous system neoplasm	0.000164	0.000861	CcSEcCtD
Rescinnamine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000164	0.00086	CcSEcCtD
Rescinnamine—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000164	0.000859	CcSEcCtD
Rescinnamine—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000161	0.000841	CcSEcCtD
Rescinnamine—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000159	0.000831	CcSEcCtD
Rescinnamine—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000158	0.000827	CcSEcCtD
Rescinnamine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000155	0.000811	CcSEcCtD
Rescinnamine—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000152	0.000795	CcSEcCtD
Rescinnamine—Rash—Etoposide—peripheral nervous system neoplasm	0.000151	0.000788	CcSEcCtD
Rescinnamine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000151	0.000788	CcSEcCtD
Rescinnamine—Headache—Etoposide—peripheral nervous system neoplasm	0.00015	0.000783	CcSEcCtD
Rescinnamine—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000149	0.000778	CcSEcCtD
Rescinnamine—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000147	0.000769	CcSEcCtD
Rescinnamine—Cough—Epirubicin—peripheral nervous system neoplasm	0.000143	0.000749	CcSEcCtD
Rescinnamine—Nausea—Etoposide—peripheral nervous system neoplasm	0.000142	0.000743	CcSEcCtD
Rescinnamine—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000142	0.000741	CcSEcCtD
Rescinnamine—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.00014	0.000731	CcSEcCtD
Rescinnamine—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000138	0.000722	CcSEcCtD
Rescinnamine—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000134	0.000701	CcSEcCtD
Rescinnamine—Infection—Epirubicin—peripheral nervous system neoplasm	0.000133	0.000696	CcSEcCtD
Rescinnamine—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000693	CcSEcCtD
Rescinnamine—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.000686	CcSEcCtD
Rescinnamine—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.000677	CcSEcCtD
Rescinnamine—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000128	0.000668	CcSEcCtD
Rescinnamine—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000124	0.000649	CcSEcCtD
Rescinnamine—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000123	0.000644	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000122	0.000639	CcSEcCtD
Rescinnamine—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000121	0.000634	CcSEcCtD
Rescinnamine—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.00012	0.000629	CcSEcCtD
Rescinnamine—Pain—Epirubicin—peripheral nervous system neoplasm	0.000115	0.000599	CcSEcCtD
Rescinnamine—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000115	0.000599	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.000591	CcSEcCtD
Rescinnamine—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.000587	CcSEcCtD
Rescinnamine—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000111	0.000582	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.00011	0.000573	CcSEcCtD
Rescinnamine—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000106	0.000557	CcSEcCtD
Rescinnamine—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.000555	CcSEcCtD
Rescinnamine—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.000555	CcSEcCtD
Rescinnamine—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000106	0.000554	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.00053	CcSEcCtD
Rescinnamine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	9.87e-05	0.000516	CcSEcCtD
Rescinnamine—Urticaria—Doxorubicin—peripheral nervous system neoplasm	9.84e-05	0.000515	CcSEcCtD
Rescinnamine—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	9.8e-05	0.000513	CcSEcCtD
Rescinnamine—Pruritus—Epirubicin—peripheral nervous system neoplasm	9.48e-05	0.000496	CcSEcCtD
Rescinnamine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	9.13e-05	0.000478	CcSEcCtD
Rescinnamine—Dizziness—Epirubicin—peripheral nervous system neoplasm	8.86e-05	0.000463	CcSEcCtD
Rescinnamine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	8.77e-05	0.000459	CcSEcCtD
Rescinnamine—Rash—Epirubicin—peripheral nervous system neoplasm	8.44e-05	0.000442	CcSEcCtD
Rescinnamine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	8.44e-05	0.000442	CcSEcCtD
Rescinnamine—Headache—Epirubicin—peripheral nervous system neoplasm	8.39e-05	0.000439	CcSEcCtD
Rescinnamine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	8.19e-05	0.000429	CcSEcCtD
Rescinnamine—Nausea—Epirubicin—peripheral nervous system neoplasm	7.96e-05	0.000416	CcSEcCtD
Rescinnamine—Rash—Doxorubicin—peripheral nervous system neoplasm	7.81e-05	0.000409	CcSEcCtD
Rescinnamine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	7.81e-05	0.000409	CcSEcCtD
Rescinnamine—Headache—Doxorubicin—peripheral nervous system neoplasm	7.76e-05	0.000406	CcSEcCtD
Rescinnamine—Nausea—Doxorubicin—peripheral nervous system neoplasm	7.36e-05	0.000385	CcSEcCtD
